China · Delayed Price · Currency is CNY Novoprotein Scientific Statistics
Total Valuation
SHA:688137 has a market cap or net worth of CNY 5.06 billion. The enterprise value is 4.28 billion.
| Market Cap | 5.06B |
| Enterprise Value | 4.28B |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688137 has 69.65 million shares outstanding. The number of shares has increased by 0.17% in one year.
| Current Share Class | 69.65M |
| Shares Outstanding | 69.65M |
| Shares Change (YoY) | +0.17% |
| Shares Change (QoQ) | -3.29% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 4.62% |
| Float | 22.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 33.14 |
| PB Ratio | 2.53 |
| P/TBV Ratio | 2.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 28.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.76, with a Debt / Equity ratio of 0.03.
| Current Ratio | 18.76 |
| Quick Ratio | 9.31 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.51 |
| Interest Coverage | -36.14 |
Financial Efficiency
Return on equity (ROE) is -4.06% and return on invested capital (ROIC) is -7.31%.
| Return on Equity (ROE) | -4.06% |
| Return on Assets (ROA) | -2.65% |
| Return on Invested Capital (ROIC) | -7.31% |
| Return on Capital Employed (ROCE) | -4.50% |
| Weighted Average Cost of Capital (WACC) | 12.67% |
| Revenue Per Employee | 240,316 |
| Profits Per Employee | -130,133 |
| Employee Count | 636 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 1.04 |
Taxes
In the past 12 months, SHA:688137 has paid 12.55 million in taxes.
| Income Tax | 12.55M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.49% in the last 52 weeks. The beta is 1.55, so SHA:688137's price volatility has been higher than the market average.
| Beta (5Y) | 1.55 |
| 52-Week Price Change | +69.49% |
| 50-Day Moving Average | 48.01 |
| 200-Day Moving Average | 44.47 |
| Relative Strength Index (RSI) | 59.07 |
| Average Volume (20 Days) | 6,389,042 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688137 had revenue of CNY 152.84 million and -82.76 million in losses. Loss per share was -1.18.
| Revenue | 152.84M |
| Gross Profit | 78.74M |
| Operating Income | -91.92M |
| Pretax Income | -70.21M |
| Net Income | -82.76M |
| EBITDA | -77.49M |
| EBIT | -91.92M |
| Loss Per Share | -1.18 |
Balance Sheet
The company has 834.77 million in cash and 50.37 million in debt, with a net cash position of 784.40 million or 11.26 per share.
| Cash & Cash Equivalents | 834.77M |
| Total Debt | 50.37M |
| Net Cash | 784.40M |
| Net Cash Per Share | 11.26 |
| Equity (Book Value) | 2.00B |
| Book Value Per Share | 29.23 |
| Working Capital | 1.72B |
Cash Flow
In the last 12 months, operating cash flow was -22.03 million and capital expenditures -77.00 million, giving a free cash flow of -99.04 million.
| Operating Cash Flow | -22.03M |
| Capital Expenditures | -77.00M |
| Depreciation & Amortization | 14.44M |
| Net Borrowing | -22.22M |
| Free Cash Flow | -99.04M |
| FCF Per Share | -1.42 |
Margins
Gross margin is 51.52%, with operating and profit margins of -60.14% and -54.15%.
| Gross Margin | 51.52% |
| Operating Margin | -60.14% |
| Pretax Margin | -45.94% |
| Profit Margin | -54.15% |
| EBITDA Margin | -50.70% |
| EBIT Margin | -60.14% |
| FCF Margin | n/a |
Dividends & Yields
SHA:688137 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.17% |
| Shareholder Yield | -0.17% |
| Earnings Yield | -1.63% |
| FCF Yield | -1.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |